Ropharma Brasov
Sentinellis health
3.7/10
Significant risks
Market capitalisation
RON 109.4M
Revenue (TTM)
RON 1.6B
I · AI Analysis
The brief
Ropharma operates across three core healthcare segments in Romania: retail pharmacies selling prescription and OTC medications, manufacturing of pharmaceuticals and supplements, and hospital services specializing in oncology, surgery, and renal transplants [Company Overview]. The company serves both consumer and medical markets through its integrated pharmacy-manufacturing-hospital model.
Ropharma is a Romanian healthcare company that operates a chain of pharmacies, manufactures pharmaceutical products and supplements, and provides hospital services including oncology and surgery [Company Overview]. The company generates RON 1.6B in revenue with 15.5% year-over-year growth, but operates on razor-thin margins (0.2% net margin) and carries significant debt at 3.2x net debt to EBITDA [Yahoo Finance]. Data coverage is limited, with no insider transaction records, institutional holder information, or sentiment analysis available.
Revenue is growing quickly, but profitability is nearly nonexistent and debt levels are concerning.
II · Recent news
What moved
2 stories · ranked by relevance
- macro2026-07-24
European Penny Stocks Spotlight: S.C. Ropharma And 2 Promising Contenders - simplywall.st
Simply Wall St
- macro2026-07-30
Ropharma SA Revenue Breakdown – BVB:RPH - TradingView
TradingView
Premium · Free with any account
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Ropharma Brasov analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare or comparable health
Want this for your watchlist?